Less invasive cardiac surgery approaches to treat ischemic heart disease – editorial
Authors:
T. Vaněk
Authors‘ workplace:
Kardiochirurgická klinika 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Zbyněk Straka, CSc.
Published in:
Vnitř Lék 2012; 58(10): 715-716
Category:
Editorial
Sources
1. Šetina M, Veselka J, Mokráček A et al. Současné možnosti robotické kardiochirurgie. Vnitř Lék 2007; 53: 986–989.
2. Iribarne A, Karpenko A, Russo MJ et al. Eight-year experience with minimally invasive cardiothoracic surgery. World J Surg 2010; 34: 611–615.
3. Borst C, Gründeman PF. Minimally invasive coronary artery bypass grafting: an experimental perspective. Circulation 1999; 99: 1400–1403.
4. Konstantinov IE. Robert H. Goetz: the surgeon who performed the first successful clinical coronary artery bypass operation. Ann Thorac Surg 2000; 69: 1966–1972.
5. Benetti FJ, Naselli G, Wood M et al. Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients. Chest 1991; 100: 312–316.
6. Buffolo E, de Andrade CS, Branco JN et al. Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 1996; 61: 63–66.
7. Straka Z, Widimsky P, Jirasek K et al. Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4. Ann Thorac Surg 2004; 77: 789–793.
8. Edmunds LH Jr. The evolution of cardiopulmonary bypass: lessons to be learned. Perfusion 2002; 17: 243–251.
9. Bednařík M. Vzpomínka na zakladatele brněnské kardiochirurgie. Jan Navrátil (1909–1992). Cor Vasa 2006; 48: K72.
10. Němec P, Bednařík M. Profesor MUDr. Jan Navrátil, DrSc., doctor honoris causa. Cor Vasa 2009; 51: 67–68.
11. Ranucci M, Balduini A, Ditta A et al. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg 2009; 87: 1311–1319.
12. Ranucci M, Isgrò G. Minimally invasive cardiopulmonary bypass: does it really change the outcome? Crit Care 2007; 11: R45.
13. Muriová K, Maláska J, Otevřel F et al. Myokardiální dysfunkce v sepsi – charakteristika a patogenetické mechanizmy. Vniř Lék 2010; 56: 220–225.
14. Maláska J, Slezák M, Muriová K et al. Myokardiální dysfunkce v sepsi – diagnostika a terapie. Vniř Lék 2010; 56: 226–232.
15. Korantzopoulos P, Kolettis TM, Galaris D et al. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115: 135–143.
16. Lábrová R. Fibrilace síní v době katétrové ablace. Vniř Lék 2010; 56: 871–879.
17. Vanek T, Brucek P, Straka Z. Activation of acute phase reactants in patients undergoing cardiac surgery. Exp Clin Cardiol 2000; 5: 98–101.
18. Vanek T, Brucek P, Straka Z et al. Development of C-reactive protein and fibronectin levels in coronary surgery patients. A comparison of on-pump, off-pump sternotomy and off-pump left anterior small thoracotomy groups. Jpn Heart J 2002; 43: 211–218.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2012 Issue 10
Most read in this issue
- Vitamin C and its physiological role with respect to the components of the immune system
- Sarcoidosis – diagnostics, prognosis and therapy. A retrospective analysis
- Acute myocardial infarction in young patients – severe failures in the system of acute and secondary care
- Febrile pancytopenia and hepatosplenomegaly as leading symptoms of visceral leishmaniasis